We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
-2.93%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$448M
AUM Growth
-$144M
(-24%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-21.61%
Top 10 Holdings %
Top 10 Hldgs %
35.17%
Holding
168
New
47
Increased
21
Reduced
40
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celestica
CLS
|
+$19M |
| 2 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$13.4M |
| 3 |
Pacira BioSciences
PCRX
|
+$11.2M |
| 4 |
Sunrun
RUN
|
+$6.27M |
| 5 |
SLB Ltd
SLB
|
+$5.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$8.83M |
| 2 |
Iron Mountain
IRM
|
+$8.24M |
| 3 |
Vistra
VST
|
+$6.26M |
| 4 |
Apollo Global Management
APO
|
+$5.38M |
| 5 |
Snowflake
SNOW
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.47% |
| 2 | Industrials | 13.37% |
| 3 | Healthcare | 9.34% |
| 4 | Utilities | 6.52% |
| 5 | Materials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Celestica
CLS
$40.3B
| $22.8M | 5.09% |
+929,200
| New | +$19M |
|
2
Bioceres Crop Solutions
BIOX
$20.6M
| $20.9M | 4.67% |
1,853,140
+437
| +0% | +$5.24K |
|
|
3
CALL
Celestica
CLS
$40.3B
| $17.2M | 3.83% |
+700,000
| New | +$14.3M |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $16.9M | 3.77% |
5,013,948
+671,948
| +15% | +$3.37M |
|
5
Itron
ITRI
$4.75B
| $16.7M | 3.73% |
276,000
-72,000
| -21% | -$4.94M |
|
|
6
Sunrun
RUN
$2.3B
| $13.9M | 3.1% |
1,106,000
+381,000
| +53% | +$6.27M |
|
7
Aspen Aerogels
ASPN
$364M
| $13.3M | 2.97% |
1,545,000
+33,322
| +2% | +$237K |
|
8
CALL
Gen Digital
GEN
$16.6B
| $12.4M | 2.76% |
700,000
+150,000
| +27% | +$2.93M |
|
9
Procore
PCOR
$7.37B
| $11.8M | 2.63% |
180,500
+24,500
| +16% | +$1.64M |
|
10
First Solar
FSLR
$21.8B
| $11.7M | 2.61% |
72,300
-5,200
| -7% | -$970K |
|
|
11
Vistra
VST
$50.1B
| $10.8M | 2.41% |
325,000
-208,500
| -39% | -$6.26M |
|
12
Flex
FLEX
$41.5B
| $10.6M | 2.37% |
522,175
+53,744
| +11% | +$1.09M |
|
|
13
Pacira BioSciences
PCRX
$1.05B
| $9.51M | 2.12% |
+310,000
| New | +$11.2M |
|
14
SentinelOne
S
$6.29B
| $8.63M | 1.93% |
512,000
-130,250
| -20% | -$2.06M |
|
|
XIFR
15
XPLR Infrastructure LP
XIFR
$1.11B
| $8.02M | 1.79% |
270,000
+265,000
| +5,300% | +$13.4M |
|
16
Delta Air Lines
DAL
$58.8B
| $7.4M | 1.65% |
200,000
+40,000
| +25% | +$1.74M |
|
|
17
CALL
Aspen Aerogels
ASPN
$364M
| $7.31M | 1.63% |
850,000
-501,000
| -37% | -$3.56M |
|
18
BellRing Brands
BRBR
$1.59B
| $6.6M | 1.47% |
160,000
| – | – |
|
19
Fluor
FLR
$6.89B
| $6.36M | 1.42% |
173,250
-105,000
| -38% | -$3.52M |
|
20
CALL
Amazon
AMZN
$2.48T
| $6.36M | 1.42% |
50,000
+20,000
| +67% | +$2.68M |
|
21
Evolv Technologies
EVLV
$1.01B
| $6.15M | 1.37% |
1,266,000
-390,000
| -24% | -$2.4M |
|
|
AMPS
22
DELISTED
Altus Power
AMPS
| $5.91M | 1.32% |
1,125,000
+96,687
| +9% | +$592K |
|
23
Pacific Biosciences
PACB
$432M
| $5.86M | 1.31% |
701,500
-204,500
| -23% | -$2.34M |
|
|
24
SLB Ltd
SLB
$74.2B
| $5.83M | 1.3% |
+100,000
| New | +$5.8M |
|
25
Legend Biotech
LEGN
$3.68B
| $5.71M | 1.27% |
85,000
-75,000
| -47% | -$5.21M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Ardsley Advisory Partners held 168 positions worth $448M, down 24% from $592M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ardsley Advisory Partners withdrew a net $96.8M in Q3 2023, closing 54 positions and reducing 40 holdings. Its most notable exit was United Therapeutics, an estimated $8.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Ardsley Advisory Partners opened a new position in Celestica worth $22.8M.
- Ardsley Advisory Partners's largest Q3 2023 buy was Celestica: 929,200 shares worth $22.8M.
- Ardsley Advisory Partners added most to XPLR Infrastructure LP in Q3 2023, an estimated $13.4M increase.
- Ardsley Advisory Partners's biggest Q3 2023 reduction was Vistra, cutting an estimated $6.26M.
- Ardsley Advisory Partners fully exited United Therapeutics in Q3 2023, selling an estimated $8.83M.
- Ardsley Advisory Partners's ten largest holdings make up 35% of its $448M portfolio in Q3 2023.
- Ardsley Advisory Partners opened 47 new positions and closed 54 in Q3 2023.
- Ardsley Advisory Partners's portfolio value fell 24% quarter-over-quarter to $448M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2023, filed 14 Nov 2023.